Picture of Scynexis logo

SCYX Scynexis Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Annual cashflow statement for Scynexis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-53.7-55.2-32.9-62.867
Depreciation
Amortisation
Non-Cash Items7.138.94-25.2-18.423.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital8.35-3.223.150.764-30.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-38.1-49.4-54.6-79.960.2
Capital Expenditures0-0.004-1.17-0.0090
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items26.26.480-27.4-34.9
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities26.26.47-1.17-27.4-34.9
Financing Cash Flow Items-2.85-6.09-1.45-3.64-0.38
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities42.39467.148.6-36.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash30.451.111.4-58.7-11.4